[Bile lake: a complication of transcatheter hepatic arterial infusion and embolization therapy (TAI, TAE)]. 1991

K Ashizawa, and N Matsunaga, and N Asoh, and M Morikawa, and I Isomoto, and A Ajimu, and T Fukuda, and J Irie, and K Hayashi
Department of Radiology, Nagasaki University School of Medicine.

A 74-year-old man with hepatocellular carcinoma developed cholangitis and bile lake in the liver after repeated TAI (anticancer drug-lipiodol suspension) and gelfoam TAE. Despite percutaneous transhepatic drainage, he died of hepatic failure 34 months after the first TAI and TAE. We speculate that cholangitis and bile lake were caused by chemical toxicity of highly concentrated anticancer drug to the bile duct and compression of the proximal bile duct by the tumor.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D002761 Cholangitis Inflammation of the biliary ductal system (BILE DUCTS); intrahepatic, extrahepatic, or both. Cholangitides
D004621 Embolization, Therapeutic A method of hemostasis utilizing various agents such as Gelfoam, silastic, metal, glass, or plastic pellets, autologous clot, fat, and muscle as emboli. It has been used in the treatment of spinal cord and INTRACRANIAL ARTERIOVENOUS MALFORMATIONS, renal arteriovenous fistulas, gastrointestinal bleeding, epistaxis, hypersplenism, certain highly vascular tumors, traumatic rupture of blood vessels, and control of operative hemorrhage. Embolotherapy,Therapeutic Embolization,Embolizations, Therapeutic,Embolotherapies,Therapeutic Embolizations
D005260 Female Females
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001646 Bile An emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL; and ELECTROLYTES. It aids DIGESTION of fats in the duodenum. Biliary Sludge,Sludge, Biliary

Related Publications

K Ashizawa, and N Matsunaga, and N Asoh, and M Morikawa, and I Isomoto, and A Ajimu, and T Fukuda, and J Irie, and K Hayashi
August 1985, Radiology,
K Ashizawa, and N Matsunaga, and N Asoh, and M Morikawa, and I Isomoto, and A Ajimu, and T Fukuda, and J Irie, and K Hayashi
January 1994, Cancer chemotherapy and pharmacology,
K Ashizawa, and N Matsunaga, and N Asoh, and M Morikawa, and I Isomoto, and A Ajimu, and T Fukuda, and J Irie, and K Hayashi
May 1998, Gan to kagaku ryoho. Cancer & chemotherapy,
K Ashizawa, and N Matsunaga, and N Asoh, and M Morikawa, and I Isomoto, and A Ajimu, and T Fukuda, and J Irie, and K Hayashi
March 1992, Gan to kagaku ryoho. Cancer & chemotherapy,
K Ashizawa, and N Matsunaga, and N Asoh, and M Morikawa, and I Isomoto, and A Ajimu, and T Fukuda, and J Irie, and K Hayashi
February 1998, Gan to kagaku ryoho. Cancer & chemotherapy,
K Ashizawa, and N Matsunaga, and N Asoh, and M Morikawa, and I Isomoto, and A Ajimu, and T Fukuda, and J Irie, and K Hayashi
October 1985, Gan to kagaku ryoho. Cancer & chemotherapy,
K Ashizawa, and N Matsunaga, and N Asoh, and M Morikawa, and I Isomoto, and A Ajimu, and T Fukuda, and J Irie, and K Hayashi
July 2023, Medicina (Kaunas, Lithuania),
K Ashizawa, and N Matsunaga, and N Asoh, and M Morikawa, and I Isomoto, and A Ajimu, and T Fukuda, and J Irie, and K Hayashi
January 2012, Nihon Jinzo Gakkai shi,
K Ashizawa, and N Matsunaga, and N Asoh, and M Morikawa, and I Isomoto, and A Ajimu, and T Fukuda, and J Irie, and K Hayashi
December 1986, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine,
K Ashizawa, and N Matsunaga, and N Asoh, and M Morikawa, and I Isomoto, and A Ajimu, and T Fukuda, and J Irie, and K Hayashi
May 1998, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!